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A
 
BSTRACT
Background:
 
Although eosinophils and fibroblasts
are believed to play important roles in the patho-
genesis of chronic allergic inflammation, the inter-
action between eosinophils and fibroblasts has not
been thoroughly elucidated. Stem cell factor (SCF) is
one of the important cytokines produced by fibro-
blasts. In the present study, we examined the effects of
some cytokines and eosinophils on SCF production by
human lung fibroblasts.
 
Methods:
 
Fibroblasts were cultured with or without
interleukin (IL)-4 for up to 48 h. In some experiments,
eosinophils were added to the wells after incubation
with or without IL-5 for 3 h and cells were cultured for
up to 48 h. At the end of the culture period, SCF in
the supernatants was measured by ELISA. In addi-
tion, the expression of SCF mRNA was examined
using reverse transcription–polymerase chain reaction
analysis.
 
Results:
 
Interleukin-4 significantly enhanced SCF pro-
duction, whereas tumor necrosis factor-
 
α
 
, interferon-
 
γ
 
and IL-1
 
α
 
 showed suppressive effects on SCF pro-
duction. When fibroblasts were cultured with IL-4 plus
IL-5-activated eosinophils, SCF production was signifi-
cantly enhanced in comparison with IL-4 alone. Experi-
ments using polymerase chain reaction amplification
revealed that IL-5-activated eosinophils enhanced SCF
production by fibroblasts through transcriptional gene
activation.
 
Conclusions:
 
These results suggest that some factor
from activated eosinophils may interact in a synergistic
fashion with IL-4 to further augment SCF production by
fibroblasts and that eosinophils may play an important
role in the activation of fibroblasts in chronic allergic
inflammation.
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I
 
NTRODUCTION
 
Stem cell factor (SCF) is a stromal cytokine and is
produced by fibroblasts, myofibroblasts, endothelial cells
and epithelial cells in peripheral tissues.
 
1–5
 
 It has been
reported that interleukin (IL)-6 or tumor necrosis factor
(TNF)-
 
α
 
 induce SCF production in human primary fore-
skin fibroblasts or synovial fibroblasts in patients with
rheumatoid arthritis, respectively.
 
6,7
 
 In addition, trans-
forming growth factor (TGF)-
 
β
 
 or basic fibroblast growth
factor enhanced SCF production in murine cell lines and
leukemia inhibitory factor or IL-4 increased SCF mRNA
in these cell lines.
 
8
 
 Stem cell factor exists in two different
forms, soluble and membrane bound, and is the ligand
for the c-kit receptor that is found on primitive hema-
topoietic cells, mature tissue mast cells and eosin-
ophils.
 
9–11
 
 Interaction of the c-kit receptor with SCF
stimulates the growth and early differentiation of hema-
topoietic cells
 
9
 
 and sustains mast cell growth and differ-
entiation in cultures of mouse bone marrow and human
cord blood.
 
12,13
 
 Furthermore, SCF primes mature dis-
persed human lung mast cells for both augmented
exocytosis of secretory granules and cytokine pro-
duction
 
14,15
 
 and activates directly mouse bone marrow-
derived mast cells to stimulate both exocytosis and
eicosanoid generation.
 
16
 
 Furthermore, SCF augments
eosinophil adhesion to the very late antigen (VLA)-4
ligands fibronectin and vascular cell adhesion molecule
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(VCAM)-1.
 
11
 
 Therefore, it is suggested that SCF affects
not only mast cells, but also eosinophils in allergic
inflammation.
Eosinophils are believed to contribute to allergic
diseases by releasing cytotoxic cationic eosinophil
granule proteins or by generating lipid mediators and
cytokines.
 
17–19
 
 In recent years, it has been reported that
eosinophils have some effects on fibroblast function.
Eosinophils are capable of both adhering to and releas-
ing mitogens for fibroblasts 
 
in vitro
 
.
 
20
 
 Eosinophil major
basic protein (MBP) interacts in a synergistic fashion with
IL-1
 
α
 
 or TGF-
 
β
 
 to further augment fibroblast IL-6-type
cytokine production.
 
21
 
 It has been reported that human
eosinophil sonicate or supernatants of cultured eosin-
ophils enhance lung fibroblast proliferation and this
activity is partially inhibited by anti-TGF-
 
β
 
 antibody.
 
22
 
However, the interaction between eosinophils and fibro-
blasts has not been thoroughly elucidated.
In the present study, we examined the effects of several
cytokines and eosinophils on SCF production by human
lung fibroblasts. As a result, we have found that IL-4
enhances SCF production by fibroblasts and that IL-5-
activated eosinophils further augment SCF production
stimulated by IL-4.
 
M
 
ETHODS
 
Purification of human eosinophils
 
Eosinophils were prepared from the venous blood of
informed healthy volunteers with eosinophil percentages
ranging from 2 to 6%. Eosinophil preparations were
purified by two-step density centrifugation, as described
previously.
 
23
 
 Erythrocytes in the preparation were lysed
by hypotonic water lysis. Eosinophils were further purified
by removal of CD16-positive cells (neutrophils) using
immunomagnetic selection by a magnetic-activated cell
sorter system (Miltenyi Biotec, Bergisch-Gladbach,
Germany).
 
24
 
 The purity of eosinophils was >95%, as
determined by microscopy of cytocentrifuge preparations
stained with May–Giemsa. Purified eosinophils were
suspended in RPMI 1640 (Life Technologies, Grand
Island, NY, USA) supplemented with 1% penicillin/
streptomycin, 0.1% human serum albumin (Miles,
Kankakee, IL, USA).
 
Reagents
 
Recombinant human (rh) IL-4, rhTNF-
 
α
 
, rhIL-6, rhIL-1
 
α
 
,
rhIL-5 and rhIL-13 were obtained from Genzyme
(Cambridge, MA, USA) and IFN-
 
γ
 
 was from Sigma
Chemical (St Louis, MO, USA). The rhTGF-
 
β
 
 was
obtained from Life Technologies. Anti-MBP monoclonal
antibody (mAb) was the kind gift of Dr Gerald J Gleich
(Mayo Clinic, Rochester, MN, USA). Anti-TGF-
 
β
 
 mAb
and anti-IL-6 mAb were from Genzyme. These mAb
were selected because of their ability to neutralize the
activities of MBP, TGF-
 
β
 
 or IL-6. These compounds were
stored in small aliquots at –70
 
°
 
C and were thawed just
before use.
 
Culture of HFL-1
 
Human lung fibroblasts (HFL-1; American Type Culture
Collection, Rockville, MD, USA) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) contain-
ing 10% fetal calf serum and 1% penicillin/streptomycin.
Cells in their 15th to 20th passages, which have the
same characteristics as other soft tissue fibroblasts (i.e.
production of collagens type I and type III),
 
25
 
 were plated
on 24-well tissue culture plates at 1.5–2 
 
×
 
 10
 
5
 
 per well
for SCF assays and cultured in a humidified atmosphere
at 37
 
°
 
C with 5% CO
 
2
 
. The monolayer achieved con-
fluency at days 2–3.
 
Stem cell factor production
 
Once confluent, the fibroblasts were cultured with or
without recombinant human cytokines for up to 48 h. In
some experiments, 500 
 
µ
 
L eosinophils (5 
 
×
 
 10
 
4
 
) was
added to the wells after incubation with or without IL-5
for 3 h and washing with medium. Then, the fibroblasts
were cultured for up to 48 h. In neutralization experi-
ments, mAbs (10 
 
µ
 
g/mL) were added to the wells at the
start of the culture. The concentration of mAbs was
decided according to our previous report.
 
23
 
 Namely, this
concentration was enough to block mediator release
from cells. At the end of the culture period, supernatants
from the wells were collected and stored at –70
 
°
 
C until
SCF measurements were performed. The SCF was meas-
ured by ELISA (R&D Systems, Minneapolis, MN, USA).
 
Polymerase chain reaction of SCF mRNA
 
After the culture period, total RNA was isolated using
Isogen (Nippon Gene, Tokyo, Japan). The SCF and
 
β
 
-actin mRNA of each sample were first reverse tran-
scribed (RT) into complementary DNA using dithiothrei-
tol (DTT), dNTP, diethylpyrocabonate-treated (DEPC)-
dH
 
2
 
O and oligo dT-primer, which was then subjected to
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conventional polymerase chain reaction (PCR) amplifica-
tion with the specific primer designed by SIGMA Genosys
Japan kk (Hokkaido, Japan). Nucleotide sequences for
primers were as follows: SCF, 5
 
′
 
-CCC AGG CTC TTT
ACT CCT GAA-3
 
′
 
 and 5
 
′
 
-CTG CCC TTG TAA GAC
TTG GCT G-3
 
′
 
; 
 
β
 
-actin, 5
 
′
 
-AGT CCG CCT AGA AGC
A-3
 
′
 
 and 5
 
′
 
-AGC CAT GTA CGT TGC TA-3
 
′
 
. The PCR
products were then resolved by Agarose gel electro-
phoresis, stained with ethidium bromide, visualized and
photographed under ultraviolet light and finally analyzed
by the National Institutes of Health image analyzer. The
PCR product size for SCF was 348 bp.
 
Presentation of data
 
All experiments were performed in duplicate and
repeated at least three times with cell preparations from
different donors. The effects of treatment examined within
the same experiments were compared by Wilcoxon’s
signed-rank test for pairs.
Unless stated otherwise, data are presented as the
mean 
 
±
 
 SEM.
 
R
 
ESULTS
 
Effects of cytokines on SCF production by 
fibroblasts
 
Figure 1 shows the effects of various cytokines on SCF
production by fibroblasts. Interleukin-4 (100 ng/mL)
induced significant potentiation of SCF production
by fibroblasts compared with control (400 
 
±
 
 70 
 
vs
 
283 
 
±
 
 39 pg/mL, respectively; 
 
n
 
 = 6; 
 
P
 
 < 0.01), whereas
IL-6 (10
 
3
 
 U/mL) and TGF-
 
β
 
 (10
 
–9
 
 mol/L) had no effect
on SCF production. Tumor necrosis factor-
 
α  
 
(10 ng/mL),
IFN-
 
γ
 
 (10
 
3
 
 U/mL) and IL-1
 
α
 
 (2.5 ng/mL) had suppres-
sive effects on SCF production by fibroblasts com-
pared with control (174 
 
±
 
 19, 153 
 
±
 
 17, 168 
 
±
 
 13 and
283 
 
±
 
 39 pg/mL, respectively; 
 
n
 
 = 6; 
 
P
 
 < 0.05). Inter-
leukin-13 had the same effect as IL-4; that is, IL-13
(100 ng/mL) enhanced SCF production compared with
control (308 
 
±
 
 36 
 
vs
 
 220 
 
±
 
 19 pg/mL, respectively;
 
n
 
 = 3; 
 
P
 
 < 0.05). Interleukin-13 (100 ng/mL) plus IL-4
(100 ng/mL) had no further potentiating effect com-
pared with either IL-13 alone or IL-4 alone (data not
shown).
 
Dose–response to IL-4
 
Figure 2 shows the dose dependence of the effect of
IL-4 on SCF production by fibroblasts. The enhancement
of SCF production by IL-4 was concentration dependent,
becoming maximal at 100 ng/mL IL-4.
 
Effects of IL-5-activated eosinophils on SCF 
production by fibroblasts
 
We examined the effects of unstimulated eosinophils or
IL-5-stimulated eosinophils on SCF production by fibro-
blasts (Fig. 3). When fibroblasts were cultured with
unstimulated eosinophils or IL-5-stimulated eosinophils,
no effect on SCF production was observed. In addition,
Fig. 1 Effects of cytokines on
stem cell factor (SCF) production
by fibroblasts.  Confluent fibro-
blast monolayers were cultured
with culture medium alone
(control) or  medium containing
100 ng/mL interleukin (IL)-4,
10 ng/mL tumor necrosis factor
(TNF),  103 U/mL IL-6, 103 U/mL
interferon (IFN)-γ, 2.5 ng/mL
IL-1α   or 10–9 mol/L transform-
ing growth factor (TGF)-β for
48 h.    The concentration of each
cytokine was selected as the most
effective concentration in prelimi-
nary experiments.    Data are the
mean ± SEM obtained from six
experiments performed    in dupli-
cate. *P < 0.05, †P < 0.01 com-
pared with control.
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when fibroblasts were cultured with IL-4 plus unstimu-
lated eosinophils, no significant enhancement was shown.
However, when fibroblasts were cultured with IL-4 plus
IL-5-stimulated eosinophils, significant enhancement of
SCF production by fibroblasts was observed compared
with IL-4 alone (500 ± 107 vs 400 ± 70 pg/mL, res-
pectively; n = 6; P < 0.05). Interleukin-5 alone had
no effect on SCF production and IL-5 plus IL-4 had no
further enhancing effect compared with IL-4 alone
(data not shown). In order to examine what from IL-5-
stimulated eosinophils affects SCF production by fibro-
blasts, we examined the effects of anti-MBP mAb,
anti-TGF-β mAb or anti-IL-6 mAb by adding the mAb at
the start of coculture of eosinophils and fibroblasts.
These mAbs had no effect on SCF enhancement.
Kinetics of fibroblast response modulation 
induced by IL-4 and IL-5-activated eosinophils
Figure 4 shows the time-course of SCF production
induced by medium alone, IL-4 or IL-4 plus IL-5-
activated eosinophils. The enhancing effect of SCF
production by IL-4 was observed after 12 h. The further
enhancement of SCF production by IL-5-activated eosin-
ophils in comparison with IL-4 alone became manifest
after 24 h. In other experiments, the enhancing effect of
IL-5-activated eosinophils plus IL-4 after 24 h was signif-
icantly greater than that of IL-4 alone (298 ± 42 vs
208 ± 31 pg/mL, respectively; n = 6; P < 0.05).
Expression of SCF mRNA
In order to confirm whether the increased production of
SCF is accompanied by the transcription of the SCF
gene, we examined the expression of SCF mRNA using
Fig. 2 Dose dependence of interleukin (IL)-4 on stem cell fac-
tor (SCF)  production by fibroblasts. Fibroblasts were cultured
with IL-4 at the concentrations indicated for 48 h.  Data are the
mean ± range of duplicate cultures in a representative of three
separate experiments.
Fig. 3 Effects of eosinophils
on stem cell factor (SCF) pro-
duction by fibroblasts. Eosin-
ophils (Eos) were incubated with
or without 10 ng/mL interleukin
(IL)-5 for 3 h. Then, fibroblasts
were cultured with or without
100 ng/mL IL-4 in the absence
or presence of unstimulated
eosinophils or IL-5-stimulated
eosinophils for 48 h. Data are
the mean ± SEM obtained from
six experiments performed in
duplicate.
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PCR amplification. As shown in Fig. 5, SCF gene expres-
sion was intensified on IL-4 stimulation and this
increased expression was further intensified by IL-5-
activated eosinophils. (The ratio of SCF gene expression
divided by β-actin gene expression was 0.66, 1.29,
0.64 and 1.79 for fibroblasts, fibroblasts + IL-4,
fibroblasts + IL-5·eosinophils and fibroblasts + IL-4 +
IL-5·eosinophils, respectively (a representative of five
different experiments).)
DISCUSSION
In the present study, we examined the effects of some
cytokines and eosinophils on SCF production by human
lung fibroblasts. Interleukin-4 significantly enhanced
SCF production, whereas TNF-α, IFN-γ, and IL-1α
showed suppressive effects on SCF production. When
fibroblasts were cultured with IL-4 plus IL-5-activated
eosinophils, significant enhancement of SCF production
was observed in comparison with IL-4 alone. Therefore,
it is suggested that some factor from activated eosin-
ophils may interact in a synergistic fashion with IL-4 to
further augment SCF production by fibroblasts.
In the present study, TNF-α, IFN-γ and IL-1α sup-
pressed SCF production by human lung fibroblasts. The
effect of TNF is different between the present study and a
previous report in which TNF-α increased SCF produc-
tion in synovial fibroblasts in patients with rheumatoid
arthritis.7 The reason for this difference is unclear. How-
ever, the difference may be due to that of fibroblasts used
in the experiments and the conditions of the experiments.
It has been reported that fibroblasts express IL-4
receptors and that stimulation with IL-4 triggers upregu-
lation of the expression of adhesion molecules and the
production of IL-6 and monocyte chemoattractant 1 in
the fibroblasts.26 In addition, it has been shown that
human mast cells stimulate fibroblast proliferation after
cell–cell contact and that this stimulatory effect of mast
cell coculture can be completely abrogated by pre-
incubation of fibroblasts with anti-IL-4R mAb.27 Thus, it is
suggested that IL-4 from mast cells activates fibroblast
function. In the present study, IL-4 activated fibroblasts to
enhance the production of SCF, which primes mast cells
for augmented cytokine production.15
It has been shown that IL-4Rα and IL-13Rα1 chains
are present in three different fibroblast populations.26
Interleukin-13 also upregulates the expression of
adhesion molecules and cytokine production similarly
Fig. 4 Time-course of stem cell factor (SCF) production.
Fibroblasts were cultured with interleukin (IL)-4 (100 ng/mL)
in the absence ( ) or presence () of IL-5-treated (10 ng/mL
for 3 h) eosinophils for the time indicated. As a control, fibro-
blasts were cultured without IL-4 in the absence of IL-5-treated
eosinophils for various times (). Data are the mean ± range
of duplicate cultures in a representative of three separate exper-
iments.
Fig. 5 Polymerase chain reaction (PCR) amplification of
cDNA specific for stem cell factor (SCF). Fibroblasts (Fb) were
stimulated with medium alone (lane 1), with interleukin (IL)-4
(lane 2), with IL-5-activated eosinophils (Eos; lane 3), or with IL-
4 plus IL-5-activated eosinophils (lane 4) for 16 h. The cDNA
was subjected to PCR amplification (35 cycles). The SCF-specif-
ic band was not observed in the case of medium alone (lane 5)
and IL-5-activated eosinophils (lane 6). β-Actin gene expression
was used as a control and results for SCF gene expression were
analyzed as the ratio to β-actin gene expression.
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to IL-4.26 In the present study, IL-13 had the same effect
as IL-4, potentiating SCF production. It is possible that
IL-13, as well as IL-4, may have an important effect on
fibroblast function.
The present study has shown that IL-5-activated eosin-
ophils further augment SCF production stimulated by
IL-4. The enhancing effect of IL-5-activated eosinophils
was also observed in the expression of SCF mRNA. It has
been reported that eosinophil MBP interacts in a syner-
gistic fashion with IL-lα or TGF-β to further augment
fibroblast IL-6-type cytokine production.21 However, anti-
MBP mAb had no effect on SCF enhancement in the
present study. Recently, we have reported that cysteinyl
leukotrienes (cysLTs) increase eotaxin production by
fibroblasts in the presence of IL-4.28 It is possible that
cysLTs from eosinophils may have some effect on SCF
production. Further investigation of the mechanism of
SCF enhancement by IL-5-activated eosinophils is
required.
In summary, the present study shows that IL-4 and
IL-5-activated eosinophils increase SCF production by
fibroblasts. It is possible that IL-4 and some factor from
eosinophils stimulate fibroblasts to produce SCF, which
activates mast cells, the important source of IL-4, and
eosinophils,11 leading to chronic allergic inflammation.
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